company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39194000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39194000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9239000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9239000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29955000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29383000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13734000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43117000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13162000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,105000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,105000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13057000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,317000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13374000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13374000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13374000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42008009.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41800000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41800000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:34:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42143000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42143000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9545000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9545000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,32598000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34685000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12754000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47439000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14841000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,200000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,75000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-125000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14966000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-17000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14949000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14949000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14949000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42761821.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42700000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42700000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 14:28:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,45480000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,45480000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9451000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9451000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36029000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36103000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8479000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44582000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8553000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,91000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,35000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-56000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8609000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8609000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8609000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8609000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47131289.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47800000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47800000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 14:40:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50487000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50487000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11537000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11537000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38950000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41228000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11142000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52370000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13420000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,91000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,40000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-51000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13471000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13471000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13471000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13471000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47327751.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47454831.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47454831.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q2,2010-04-01,2010-06-30,2011-08-02 16:53:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53633000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53633000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11573000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11573000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42060000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40337000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14429000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,54766000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12706000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,101000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,53000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-48000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12754000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12754000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12754000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12754000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47592975.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47651114.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47651114.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 15:04:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,61829000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,61829000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17164000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17164000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44665000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,47007000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13955000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60962000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16297000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,139000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,39000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-100000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16397000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16397000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16397000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16397000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47426849.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47426849.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47400000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,58369000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,58369000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11252000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11252000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,47117000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43159000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15754000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58913000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11796000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,91000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,41000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-50000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11846000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11846000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11846000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11846000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47765284.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47809054.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47809054.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 07:01:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,65937000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,65937000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14379000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14379000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,51558000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43368000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13315000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56683000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5125000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,88000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,64000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-24000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5149000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5149000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5149000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5149000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47830131.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47830131.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46800000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q2,2011-04-01,2011-06-30,2012-07-31 11:55:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,66731000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,66731000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13527000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13527000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,53204000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43262000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14161000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57423000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4219000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,179000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,161000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4058000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4058000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4058000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4058000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50700000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50700000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47933447.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 07:00:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,73278000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,73278000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16504000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16504000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,56774000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50098000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18718000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,68816000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12042000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,39000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-284000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,502000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,179000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11863000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11863000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11863000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11863000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47886672.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47886672.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47700000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,73606000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,73606000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16602000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16602000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,57004000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,46946000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11993000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58939000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1935000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,187000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,187000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1748000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1748000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1748000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1748000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48250572.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43700000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43700000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 07:01:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,78171000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,78171000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17804000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17804000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,60367000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42585000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10186000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52771000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7596000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,128000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,128000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7724000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7724000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7724000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7724000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48575418.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49172212.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48300000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 17:17:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,71043000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,71043000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15849000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15849000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,55194000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,55344000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10591000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65935000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10741000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,253000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,253000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10488000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10488000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10488000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10488000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49078321.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49078321.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49900000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 14:14:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,172461000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,172461000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28082000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28082000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,144379000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40660000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13162000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53822000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,90557000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,39000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-187000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,125000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-101000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,90456000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,90456000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,90456000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,90456000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48770229.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.85
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49277570.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.83
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48800000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.85
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,66172000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,66172000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15089000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15089000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,51083000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44310000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11858000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56168000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5085000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3004000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-71000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3075000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8160000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8160000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8160000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8160000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49295399.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49295399.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49247332.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 07:01:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,100519000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,100519000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27216000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27216000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,73303000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,74894000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13626000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,10895000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2258000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,101673000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28370000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7134000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,234000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6900000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35270000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-77920000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42650000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,42650000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,42650000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49280151.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.87
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49583377.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.86
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49280151.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:01:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.87
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,108140000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,108140000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,33553000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,33553000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,74587000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62809000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11816000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,15085000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4671000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,94381000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19794000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8912000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,105000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8807000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28601000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28601000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28601000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28601000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49384637.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.58
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49384637.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.58
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49384637.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 07:03:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.58
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,125884000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,125884000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,36157000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,36157000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,89727000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,68177000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12911000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,19008000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4467000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,104563000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14836000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9605000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,110000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9495000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24331000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-377000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23954000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23954000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23954000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49337724.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49337724.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.48
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48800000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,88519000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,88519000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18094000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18094000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,70425000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,78016000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10994000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,19761000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,7717000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,116488000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-46063000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9520000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-56000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9576000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-55639000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,338000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55977000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55977000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-55977000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49819258.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.12
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49819258.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.12
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49798485.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 07:01:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.12
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,83018000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,83018000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30094000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30094000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,52924000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,69205000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11303000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,19970000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-20398000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,80080000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27156000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9513000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,56000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9457000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-36613000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-118000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36495000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36495000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36495000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50245490.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.73
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50245490.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.73
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50245490.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q2,2014-04-01,2014-06-30,2014-08-07 07:01:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.73
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,109624000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,109624000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25713000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25713000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,83911000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,72492000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11222000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,19713000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,16514000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-12834000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,107107000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23196000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9577000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,22000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9555000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32751000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-101000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32650000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32650000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32650000.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50403556.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.65
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50403556.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.65
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50403556.0
"Auxilium Pharmaceuticals, Inc.",AUXL,,0001182129,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 07:03:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.65
